State of the Art Left Main and Multivessel Revascularization in 2023: Where Does the Data Stand?
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Grant Support/Research Contract - Abbott
- Consultant Fee/Honoraria/Speaker's Bureau - Biotronik; Medtronic; Philips; Boston Scientific Corporation